Deprecated: Return type of Requests_Cookie_Jar::offsetExists($key) should either be compatible with ArrayAccess::offsetExists(mixed $offset): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in /home/finbold-prod/ on line 63
Skip to content
ILMN Illumina Inc NASDAQ
224.55 USD -0.18% -0.40
OPEN 223.09
DAY RANGE 225.13 - 220.05
52 WEEK RANGE 371.16 - 173.45
Interactive Brokers Logotype

Buy ILMN stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 35.5B
Enterprise value 37B
Forward pe 71.97116
Peg ratio 71.97116
Price to sales ttm 7.7534895
Price to book mrq 5.376383
Enterprise to revenue 8.071
Enterprise to ebitda 64.567


Fiscal year ends 2023-01-01
Most recent quarter 2023-01-01
Profit margin -0.96072996
Operating margin 0.039049998
Return on assets ttm 0.00815
Return on equity ttm -0.50799
Income statement
Revenue ttm 4.6B
Revenue per share ttm 29.197
Quarterly revenue growth -0.097
Gross profit ttm 3.1B
Ebitda 617M
Net income to common ttm -4403999744
Diluted eps ttm -27.84
Quarterly earnings growth yoy -0.09674728940784
Balance sheet
Total cash mrq 2B
Total cash per share mrq 12.892
Total debt mrq 3.6B
Total debt to equity mrq 53.872
Current ratio mrq 1.284
Book value per share mrq 41.766
Cash flow
Operating cash flow ttm 392M
Levered free cash flow ttm 666.6M

Stock statistics

Shares outstanding 158M
Float shares 157.7M
Avg 10 volume 1.7M
Avg 30 volume 1.5M
Shares short 4.3M
Short ratio 3.41
Short percent of shares outstanding 0.031600002
Percent held by insiders 0.00402
Percent held by institutions 0.93481004

Stock price summary

Fifty two week low 173.45
Fifty two week high 371.16
Fifty two week change -54.531
Beta 1.145562
Day 50 ma 208.6578
Day 200 ma 207.8443

Dividends and splits

Last split factor 2-for-1 split
Last split date 2008-09-23

Illumina (ILMN) company profil

Illumina Inc. (NASDAQ: ILMN) is an American company that provides sequencing- and array-based solutions. The company’s products and services serve customers in various markets, supporting the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Illumina also offers instruments and consumables used in genetic analysis.